Selected Review Articles

  • Andrikoula M, Hardiman P & Prelevic GM
    Menopausal hot flush: Is it only a nuisance or also a marker of cardiovascular disease risk?
    Gynaecological Endocrinology, 2009; 25: 450-454.
  • Andrikoula M & Prelevic GM
    Menopausal hot flushes revisited
    Climacteric, 2009; 12: 3-15.
  • Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P
    Polycystic Ovary Syndrome, diabetes and cardiovascular disease risk and risk factors
    Journal of Obstetrics and Gynaecology, 2004; 24: 613-621.
  • Tsilchorozidou T & Prelevic GM
    The role of metformon in the management of Polycystic Ovary Syndrome
    Current Opinion in Obstetrics and Gynecology, 2003; 15: 483-488.
  • Kocjan T & Prelevic GM
    Hormone replacement therapy update: who should we be prescribing this to now?
    Current Opinion in Obstetrics and Gynecology, 2003; 15: 459-464.
  • Prelevic GM
    Osteoporosis in men
    Journal of the Royal Society of Medicine, 2001; 94: 620-623.
  • Prelevic GM
    The effects of sex steroids on the female voice
    Musical Performance, 2000; 2(4): 93-103.
  • Randeva H, Davies M & Prelevic GM
    Prolactinoma and pregnancy
    British Journal of Obstetrics & Gynaecology, 2000; 107: 1064-1068.
  • Ginsburg J & Prelevic GM
    Lack of significant hormonal effects and controlled trials of phyto-oestrogens
    Lancet, 2000; 355: 163-164.
  • Prelevic GM & HS Jacobs
    Menopause and post-menopause
    Bailliere's Clinical Endocrinology and Metabolism, 1997; 11: 311-340.
  • Prelevic GM
    Insulin resistance in Polycystic Ovary Syndrome
    Current Opinion in Obstetrics and Gynecology, 1997; 9: 193-201.